Lactiga
PrivateLast Round
Series A
Sep 4, 2025
Total Funding Raised
$3.61M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Lactiga is a biotechnology company developing novel mucosal antibodies derived from human breastmilk to address chronic disease and immune dysregulation in vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lactiga Comparables
Compare Lactiga with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Grifols | 71% | |
| Octapharma AG | 67% | |
| Takeda | 66% | |
Lactiga Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 4, 2025 | ||||
| Grant | Sep 4, 2025 | ||||
| Grant | Feb 3, 2025 | ||||
| Grant | Sep 21, 2022 | ||||
| Pre Seed | Sep 21, 2022 | ||||
Seed | Nov 2, 2020 |
Key People
Founding team and executive leadership
Lactiga Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Innovation Factory | Grant |
| 1517 Fund | Pre Seed |
| NIH RADx | Grant |
| LaunchYU | Accelerator |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 2479% MoM, reaching 1.1K.
- Feb 3, 2025
Received grant from National Institute of Allergy and Infectious Diseases and NIH RADx.
Lactiga Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lactiga's valuation, stock price, and market status.